Day One Biopharmaceuticals, Inc.
DAWN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $39,795 | $33,908 | $30,761 | $29,208 |
| % Growth | 17.4% | 10.2% | 5.3% | – |
| Cost of Goods Sold | $4,480 | $3,765 | $2,884 | $2,982 |
| Gross Profit | $35,315 | $30,143 | $27,877 | $26,226 |
| % Margin | 88.7% | 88.9% | 90.6% | 89.8% |
| R&D Expenses | $31,419 | $36,149 | $39,619 | $61,823 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $28,147 | $28,968 | $29,325 | $29,735 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $59,566 | $65,117 | $68,944 | $91,558 |
| Operating Income | -$24,251 | -$34,974 | -$41,067 | -$65,332 |
| % Margin | -60.9% | -103.1% | -133.5% | -223.7% |
| Other Income/Exp. Net | $4,525 | $4,652 | $5,071 | $6,092 |
| Pre-Tax Income | -$19,726 | -$30,322 | -$35,996 | -$59,240 |
| Tax Expense | $0 | $0 | $0 | $6,474 |
| Net Income | -$19,726 | -$30,322 | -$35,996 | -$65,714 |
| % Margin | -49.6% | -89.4% | -117% | -225% |
| EPS | -0.19 | -0.29 | -0.35 | -0.7 |
| % Growth | 34.5% | 17.1% | 50% | – |
| EPS Diluted | -0.19 | -0.29 | -0.35 | -0.7 |
| Weighted Avg Shares Out | 103,381 | 103,069 | 102,710 | 93,624 |
| Weighted Avg Shares Out Dil | 103,381 | 103,069 | 102,710 | 93,624 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4,559 | $4,671 | $5,094 | $6,052 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $939 | $964 | $894 | $759 |
| EBITDA | -$18,787 | -$29,358 | -$35,102 | -$58,481 |
| % Margin | -47.2% | -86.6% | -114.1% | -200.2% |